M&T Bank
PMVP icon

M&T Bank’s PMV Pharmaceuticals PMVP Stock Holding History

M&T Bank’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-399,548
Closed -$604K – 1649
2024
Q4 		$604K Hold
399,548
– – ﹤0.01% 1096
2024
Q3 		$596K Buy
399,548
+141,064
+55% +$218K ﹤0.01% 1106
2024
Q2 		$418K Hold
258,484
– – ﹤0.01% 1183
2024
Q1 		$440K Buy
258,484
+60,802
+31% +$114K ﹤0.01% 1185
2023
Q4 		$612K Buy
+197,682
New +$523K ﹤0.01% 1050
2023
Q2 		– Sell
-45,090
Closed -$216K – 1721
2023
Q1 		$216K Buy
45,090
+3,672
+9% +$25.8K ﹤0.01% 1442
2022
Q4 		$360K Buy
41,418
+6,854
+20% +$73.1K ﹤0.01% 1226
2022
Q3 		$412K Sell
34,564
-350
-1% -$5.06K ﹤0.01% 1168
2022
Q2 		$498K Buy
34,914
+25,131
+257% +$366K ﹤0.01% 1010
2022
Q1 		$204K Buy
9,783
+812
+9% +$14.3K ﹤0.01% 1381
2021
Q4 		$207K Buy
8,971
+489
+6% +$11.8K ﹤0.01% 1444
2021
Q3 		$253K Buy
+8,482
New +$271K ﹤0.01% 1321
2021
Q1 		– Sell
-4,521
Closed -$278K – 1681
2020
Q4 		$278K Buy
+4,521
New +$177K ﹤0.01% 1372

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

M&T Bank's PMVP Position: Q1 2025 in Review

M&T Bank sold out of PMV Pharmaceuticals (PMVP) in Q1 2025, closing a stake of 399,548 shares — an estimated $604K sold.

M&T Bank first reported a position in PMVP in Q4 2020 and held it in 13 quarters. The position peaked at $612K in Q4 2023. 55 funds tracked by Wall St. Rank hold PMVP as of Q1 2025.

  • M&T Bank reported no remaining PMV Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 399,548 PMV Pharmaceuticals shares in Q1 2025, an estimated $604K.
  • M&T Bank first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 13 quarters.
  • M&T Bank's PMV Pharmaceuticals position peaked at $612K in Q4 2023.
  • 55 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.